Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1991 1
1995 2
2000 1
2013 1
2015 1
2016 1
2017 1
2018 2
2019 3
2020 15
2021 14
2022 20
2023 24
2024 40
2025 53
2026 28

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

168 results

Results by year

Filters applied: . Clear all
Page 1
Low-Dose Oral Minoxidil Initiation for Patients With Hair Loss: An International Modified Delphi Consensus Statement.
Akiska YM, Mirmirani P, Roseborough I, Mathes E, Bhutani T, Ambrosy A, Aguh C, Bergfeld W, Callender VD, Castelo-Soccio L, Cotsarelis G, Craiglow BG, Desai NS, Doche I, Duque-Estrada B, Elston DM, Goh C, Goldberg LJ, Grimalt R, Jabbari A, Jolliffe V, King BA, LaSenna C, Lenzy Y, Lester JC, Lortkipanidze N, Lo Sicco KI, McMichael A, Meah N, Mesinkovska N, Miteva M, Mostaghimi A, Ovcharenko Y, Piliang M, Piraccini BM, Rakowska A, Salkey KS, Schmidt A, Shapiro J, Sibbald C, Sinclair R, Suchonwanit P, Taylor S, Tosti A, Vañó-Galván S, Wall DR, Fu JM. Akiska YM, et al. JAMA Dermatol. 2025 Jan 1;161(1):87-95. doi: 10.1001/jamadermatol.2024.4593. JAMA Dermatol. 2025. PMID: 39565602 Free article.
IMPORTANCE: The results of small studies suggest that off-label use of low-dose oral minoxidil (LDOM) may be safe and effective for patients with hair loss, but larger trials and standardized guidelines are lacking. ...Other critical topics for further …
IMPORTANCE: The results of small studies suggest that off-label use of low-dose oral minoxidil (LDOM) may be saf …
Efficacy and safety of low-dose oral minoxidil in the management of androgenetic alopecia.
Gupta AK, Talukder M, Shemer A. Gupta AK, et al. Expert Opin Pharmacother. 2024 Feb;25(2):139-147. doi: 10.1080/14656566.2024.2314087. Epub 2024 Feb 6. Expert Opin Pharmacother. 2024. PMID: 38315101 Review.
INTRODUCTION: Treating alopecia can be challenging. The available treatments are topical minoxidil, low-dose oral minoxidil (LDOM), and 5-alpha reductase inhibitors like finasteride and dutasteride. ...Recent research has suggested that oral …
INTRODUCTION: Treating alopecia can be challenging. The available treatments are topical minoxidil, low-dose oral …
Oral Minoxidil vs Topical Minoxidil for Male Androgenetic Alopecia: A Randomized Clinical Trial.
Penha MA, Miot HA, Kasprzak M, Müller Ramos P. Penha MA, et al. JAMA Dermatol. 2024 Jun 1;160(6):600-605. doi: 10.1001/jamadermatol.2024.0284. JAMA Dermatol. 2024. PMID: 38598226 Free PMC article. Clinical Trial.
IMPORTANCE: There has been increased interest in low-dose oral minoxidil for androgenetic alopecia (AGA) treatment. However, the efficacy of oral minoxidil for male AGA is yet to be evaluated in comparative therapeutic trials. ...INTERVEN …
IMPORTANCE: There has been increased interest in low-dose oral minoxidil for androgenetic alopecia (AGA) treatme …
Oral minoxidil treatment for hair loss: A review of efficacy and safety.
Randolph M, Tosti A. Randolph M, et al. J Am Acad Dermatol. 2021 Mar;84(3):737-746. doi: 10.1016/j.jaad.2020.06.1009. Epub 2020 Jul 2. J Am Acad Dermatol. 2021. PMID: 32622136 Review.
OBJECTIVE: In recent years, oral minoxidil at low dose has been proposed as a safe alternative. This study reviewed articles in which oral minoxidil was used to treat hair loss to determine its efficacy and safety as an alternative to top …
OBJECTIVE: In recent years, oral minoxidil at low dose has been proposed as a safe alternative. This study revie …
Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients.
Vañó-Galván S, Pirmez R, Hermosa-Gelbard A, Moreno-Arrones ÓM, Saceda-Corralo D, Rodrigues-Barata R, Jimenez-Cauhe J, Koh WL, Poa JE, Jerjen R, Trindade de Carvalho L, John JM, Salas-Callo CI, Vincenzi C, Yin L, Lo-Sicco K, Waskiel-Burnat A, Starace M, Zamorano JL, Jaén-Olasolo P, Piraccini BM, Rudnicka L, Shapiro J, Tosti A, Sinclair R, Bhoyrul B. Vañó-Galván S, et al. J Am Acad Dermatol. 2021 Jun;84(6):1644-1651. doi: 10.1016/j.jaad.2021.02.054. Epub 2021 Feb 24. J Am Acad Dermatol. 2021. PMID: 33639244
BACKGROUND: The major concern regarding the use of low-dose oral minoxidil (LDOM) for the treatment of hair loss is the potential risk of systemic adverse effects. ...RESULTS: A total of 1404 patients (943 women [67.2%] and 461 men [32.8%]) with a mean …
BACKGROUND: The major concern regarding the use of low-dose oral minoxidil (LDOM) for the treatment of hair loss …
Low-dose oral minoxidil does not significantly affect blood pressure: A systematic review and meta-analysis.
Chen M, Weichert M, Guo W, Ruzic R, Briley J. Chen M, et al. J Am Acad Dermatol. 2025 Mar;92(3):554-555. doi: 10.1016/j.jaad.2024.10.057. Epub 2024 Nov 7. J Am Acad Dermatol. 2025. PMID: 39521141
INTRODUCTION: Minoxidil, traditionally used as an antihypertensive, is now widely used for treating various forms of alopecia due to its vasodilatory effects. While topical minoxidil has been the standard treatment, low-dose oral minoxidil …
INTRODUCTION: Minoxidil, traditionally used as an antihypertensive, is now widely used for treating various forms of alopecia due to …
Low-dose oral minoxidil as treatment for non-scarring alopecia: a systematic review.
Sharma AN, Michelle L, Juhasz M, Muller Ramos P, Atanaskova Mesinkovska N. Sharma AN, et al. Int J Dermatol. 2020 Aug;59(8):1013-1019. doi: 10.1111/ijd.14933. Epub 2020 Jun 9. Int J Dermatol. 2020. PMID: 32516434
BACKGROUND: Topical minoxidil has been used for almost 40 years to treat alopecia. There is growing evidence supporting off-label use of low-dose oral minoxidil. OBJECTIVE: To conduct a systematic review evaluating the use of oral mino …
BACKGROUND: Topical minoxidil has been used for almost 40 years to treat alopecia. There is growing evidence supporting off-label use …
Effectiveness and safety of low-dose oral minoxidil in male androgenetic alopecia.
Jimenez-Cauhe J, Saceda-Corralo D, Rodrigues-Barata R, Hermosa-Gelbard A, Moreno-Arrones OM, Fernandez-Nieto D, Vaño-Galvan S. Jimenez-Cauhe J, et al. J Am Acad Dermatol. 2019 Aug;81(2):648-649. doi: 10.1016/j.jaad.2019.04.054. Epub 2019 May 2. J Am Acad Dermatol. 2019. PMID: 31054970 No abstract available.
Clinical efficacy and safety of low-dose oral minoxidil versus topical solution in the improvement of androgenetic alopecia: A randomized controlled trial.
Asilian A, Farmani A, Saber M. Asilian A, et al. J Cosmet Dermatol. 2024 Mar;23(3):949-957. doi: 10.1111/jocd.16086. Epub 2023 Nov 29. J Cosmet Dermatol. 2024. PMID: 38031516 Clinical Trial.
However, low-dose oral minoxidil has been used off-label with good clinical efficacy and safety. ...Therefore, 1 mg oral minoxidil may be as effective and safe as standard topical minoxidil in female and male pattern hair loss....
However, low-dose oral minoxidil has been used off-label with good clinical efficacy and safety. ...Therefore, 1 …
Minoxidil: a comprehensive review.
Gupta AK, Talukder M, Venkataraman M, Bamimore MA. Gupta AK, et al. J Dermatolog Treat. 2022 Jun;33(4):1896-1906. doi: 10.1080/09546634.2021.1945527. Epub 2021 Jul 20. J Dermatolog Treat. 2022. PMID: 34159872 Free article. Review.
Topical minoxidil causes hair regrowth in both frontotemporal and vertex areas. The 5% solution and foam were not significantly different in efficacy from the 2% solution.Oral and Sublingual minoxidil (not FDA approved; off-label): After 6 months of administr …
Topical minoxidil causes hair regrowth in both frontotemporal and vertex areas. The 5% solution and foam were not significantly diffe …
168 results